Q2 EPS Estimates for Cytokinetics Cut by HC Wainwright
Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) – Equities researchers at HC Wainwright decreased their Q2 2025 EPS estimates for Cytokinetics in a research report issued to clients and investors on Wednesday, May 7th. HC Wainwright analyst J. Pantginis now anticipates that the biopharmaceutical company will post earnings per share of ($1.47) for the quarter, down […]
Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) – Equities researchers at HC Wainwright decreased their Q2 2025 EPS estimates for Cytokinetics in a research report issued to clients and investors on Wednesday, May 7th. HC Wainwright analyst J. Pantginis now anticipates that the biopharmaceutical company will post earnings per share of ($1.47) for the quarter, down […]
